000 | 01446 a2200409 4500 | ||
---|---|---|---|
005 | 20250511221400.0 | ||
264 | 0 | _c19910802 | |
008 | 199108s 0 0 eng d | ||
022 | _a0740-3194 | ||
024 | 7 |
_a10.1002/mrm.1910170208 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTofts, P S | |
245 | 0 | 0 |
_aMeasurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. _h[electronic resource] |
260 |
_bMagnetic resonance in medicine _cFeb 1991 |
||
300 |
_a357-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBlood-Brain Barrier _xphysiology |
650 | 0 | 4 |
_aBrain Diseases _xblood |
650 | 0 | 4 | _aContrast Media |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGadolinium _xblood |
650 | 0 | 4 | _aGadolinium DTPA |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImage Enhancement _xmethods |
650 | 0 | 4 |
_aKidney _xmetabolism |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMultiple Sclerosis _xblood |
650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacokinetics |
650 | 0 | 4 |
_aPentetic Acid _xpharmacokinetics |
650 | 0 | 4 | _aPermeability |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aKermode, A G | |
773 | 0 |
_tMagnetic resonance in medicine _gvol. 17 _gno. 2 _gp. 357-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mrm.1910170208 _zAvailable from publisher's website |
999 |
_c2068376 _d2068376 |